Abstract
We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.
Original language | English |
---|---|
Pages (from-to) | 55-57 |
Number of pages | 3 |
Journal | Pediatric Infectious Disease Journal |
Volume | 28 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2009 |
Keywords
- BK virus
- cidofovir
- hemorrhagic cystitis
- probenecid
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Infectious Diseases
- Microbiology (medical)